Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
1995-12-13
pubmed:abstractText
To determine whether the effects of topically administered timolol in an individual would be dependent on the presence or absence in that individual of the P-450 enzyme CYP2D6 and whether the effects of topically administered timolol would be increased and its metabolism decreased by the oral administration of quinidine, a known inhibitor of CYP2D6.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0098-7484
pubmed:author
pubmed:issnType
Print
pubmed:volume
274
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1611-3
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:7474246-Administration, Oral, pubmed-meshheading:7474246-Administration, Topical, pubmed-meshheading:7474246-Adrenergic beta-Antagonists, pubmed-meshheading:7474246-Adult, pubmed-meshheading:7474246-Cross-Over Studies, pubmed-meshheading:7474246-Cytochrome P-450 CYP2D6, pubmed-meshheading:7474246-Cytochrome P-450 Enzyme System, pubmed-meshheading:7474246-Debrisoquin, pubmed-meshheading:7474246-Drug Interactions, pubmed-meshheading:7474246-Enzyme Inhibitors, pubmed-meshheading:7474246-Exercise Test, pubmed-meshheading:7474246-Heart Rate, pubmed-meshheading:7474246-Humans, pubmed-meshheading:7474246-Male, pubmed-meshheading:7474246-Mixed Function Oxygenases, pubmed-meshheading:7474246-Ophthalmic Solutions, pubmed-meshheading:7474246-Phenotype, pubmed-meshheading:7474246-Quinidine, pubmed-meshheading:7474246-Single-Blind Method, pubmed-meshheading:7474246-Timolol
pubmed:articleTitle
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
pubmed:affiliation
Department of Pharmacology, Meharry Medical College, Nashville, Tenn, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial